Work

Perioperative troponin surveillance for myocardial injury in patients with higher cardiovascular risk undergoing non-cardiac surgery: an international survey of anaesthesiologists

Year: 2026
Type: article
Study design: Observational Study
Abstract: Introduction Perioperative myocardial infarction/injury (PMI) or myocardial injury after non-cardiac surgery (MINS) is common, mostly clinically silent and associated with increased mortality. Guidelines recommend perioperative high-sensitivity cardiac troponin surveillance in selected higher-risk patients, yet real-world implementation is uncertain. We assessed current troponin monitoring practices, adherence to guideline-recommended sampling timepoints, perceived barriers and reported use of dabigatran for PMI/MINS. Methods We conducted an anonymous, international, web-based survey of clinicians working in anaesthesia between May 2024 and March 2025. This analysis focused on a supplemental four-question module addressing frequency of perioperative troponin monitoring in higher cardiac-risk patients undergoing non-cardiac surgery, sampling patterns, reasons for not monitoring and institutional dabigatran use. Respondents were described overall and compared between European and non-European respondents in an exploratory analysis. Results Of 261 respondents from at least 26 countries, fewer than half monitored troponin routinely (22% almost always, 23% usually), 32% monitored sometimes, 17% rarely and 7% never. Among those monitoring at least rarely ( n = 244), 55% reported predefined sampling consistent with 2022 ESC recommendations, 10% used alternative routine timepoints and 31% measured troponin only in symptomatic patients. Of the options provided, follow-up issues (33%), financial constraints (29%), and a perceived minimal/no therapeutic impact (24%) were indicated as reasons for not performing routine monitoring. Dabigatran was rarely used: 5% reported routine use and 17% use in select cases; 53% were unaware of dabigatran use for PMI/MINS. Conclusions Perioperative troponin surveillance in higher cardiac-risk patients is heterogeneous, with only about half of monitoring clinicians following guideline-recommended sampling timepoints and substantial reliance on symptom-triggered testing. When troponin was not monitored, common reasons cited were logistical and financial barriers and uncertainty about downstream management. Pragmatic, resourced pathways linking troponin surveillance to structured interpretation, follow-up and treatment decisions may improve consistency. Clinical trial number Not applicable.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,190
OpenAlex ID: W7235622794
FWCI:
Cites:
Cited by:
Related to: 10